Viral infections in celiac disease: what should be considered for better management
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Viral infections in celiac disease: what should be considered for better management ; volume:25 ; number:1 ; day:28 ; month:12 ; year:2024 ; pages:1-13 ; date:12.2025
Clinical and experimental medicine ; 25, Heft 1 (28.12.2024), 1-13, 12.2025
- Classification
-
Medizin, Gesundheit
- Creator
-
Asri, Nastaran
Mohammadi, Shahnaz
Jahdkaran, Mahtab
Rostami-Nejad, Mohammad
Rezaei-Tavirani, Mostafa
Mohebbi, Seyed Reza
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10238-024-01542-6
- URN
-
urn:nbn:de:101:1-2503062104488.536883385289
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Asri, Nastaran
- Mohammadi, Shahnaz
- Jahdkaran, Mahtab
- Rostami-Nejad, Mohammad
- Rezaei-Tavirani, Mostafa
- Mohebbi, Seyed Reza
- SpringerLink (Online service)
Other Objects (12)
What should be considered during epicutaneous patch testing?
Who Should Be Considered for Islet Transplantation Alone?
Which patients should be considered for gene therapy
All Things Considered, Should Egalitarian Movements Accept Philanthropic Funding?
Powerpenia Should be Considered a Biomarker of Healthy Aging
Hemodialysis dose and frequency should be considered in subgroup analysis
Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered
Capsule endoscopy diagnosis of radiation enteritis in a patient previously considered to have celiac sprue
Defining the quality of urban life: Which factors should be considered?
Response to: ‘Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered’
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Should the meniscal height be considered for preoperative sizing in meniscal transplantation?
What should be considered during epicutaneous patch testing?
Who Should Be Considered for Islet Transplantation Alone?
Which patients should be considered for gene therapy
All Things Considered, Should Egalitarian Movements Accept Philanthropic Funding?
Powerpenia Should be Considered a Biomarker of Healthy Aging
Hemodialysis dose and frequency should be considered in subgroup analysis
Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered
Capsule endoscopy diagnosis of radiation enteritis in a patient previously considered to have celiac sprue
Defining the quality of urban life: Which factors should be considered?
Response to: ‘Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered’
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Should the meniscal height be considered for preoperative sizing in meniscal transplantation?
What should be considered during epicutaneous patch testing?
Who Should Be Considered for Islet Transplantation Alone?
Which patients should be considered for gene therapy
All Things Considered, Should Egalitarian Movements Accept Philanthropic Funding?
Powerpenia Should be Considered a Biomarker of Healthy Aging
Hemodialysis dose and frequency should be considered in subgroup analysis
Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered
Capsule endoscopy diagnosis of radiation enteritis in a patient previously considered to have celiac sprue
Defining the quality of urban life: Which factors should be considered?
Response to: ‘Failed oral immunotherapy should be considered as a risk factor for fatal anaphylaxis, and omalizumab treatment considered’
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?